Royal Bank Of Canada Edesa Biotech, Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.91 - $2.63 $50 - $147	-56 Reduced 3.91%	1,375 $1,000
Q1 2022 May 16, 2022	SELL	$2.72 - $5.97 $1,360 - $2,985	-500 Reduced 25.89%	1,431 $4,000
Q4 2021 Feb 14, 2022	BUY	$5.17 - $8.65 $2,585 - $4,325	500 Added 34.94%	1,931 $11,000
Q3 2021 Nov 15, 2021	BUY	$4.2 - $11.92 $4,620 - $13,112	1,100 Added 332.33%	1,431 $11,000
Q2 2021 Aug 16, 2021	BUY	$4.93 - $6.69 $1,631 - $2,214	331 New	331 $2,000

Ticker EDSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,462,300
Market Cap $38.2M
Description
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.